A cancer diagnosis is no longer only a question of whether a tumour can be removed, treated or placed into remission. For thousands of Nigerians, it can also become a prolonged struggle with pain, treatment costs, lost income, family pressure and limited access to specialised care.
That reality has renewed attention on a message from the Federal Government that remains relevant beyond the immediate announcement: cancer patients should not simply be sent home because a hospital can no longer offer treatment aimed at curing the disease.
Dr Uchechukwu Nwokwu, National Coordinator of the National Cancer Control Plan at the Federal Ministry of Health and Social Welfare, said patients who still require hospital based care should either continue receiving appropriate treatment or be promptly referred to another facility with the necessary capacity.
His position is particularly significant against the scale of Nigeria’s cancer burden. The latest International Agency for Research on Cancer estimates, published in 2026 using 2024 data, put the global cancer burden at 20.6 million new cases and 9.8 million deaths in 2024.
For Nigeria, the most recent country specific GLOBOCAN estimates currently available show 127,763 new cancer cases and 79,542 cancer deaths in 2022. Women accounted for 79,667 new cases and 46,637 deaths, while men accounted for 48,096 cases and 32,905 deaths.
Those figures are estimates rather than a complete national case count, an important distinction given continuing efforts to strengthen cancer registration in Nigeria.
The five year prevalence estimate was 269,109 people, meaning that many Nigerians were living with cancer or its consequences beyond the year in which they were diagnosed.
That is where the debate over palliative care becomes critical.
Cancer treatment can involve surgery, chemotherapy, radiotherapy, targeted medicines and combinations of these approaches, depending on the cancer type, stage and individual clinical circumstances.
But advanced cancer can reach a point where treatment aimed at curing the disease is no longer feasible. That does not mean the patient’s medical needs disappear.
Nwokwu argued that patients should only be discharged when they are clinically stable, able to take treatment orally and unlikely to require further intervention or monitoring. Where a facility lacks the capacity to continue care, he said referral should be arranged rather than simply sending the patient home.
This distinction reflects established cancer care principles. WHO identifies palliative care as an essential component of cancer management, alongside prevention, early diagnosis and treatment. It is designed to prevent and relieve physical, psychological, social and spiritual suffering.
WHO says it is most effective when introduced early and integrated into the health system, rather than reserved for the final days or weeks of life.
Nigeria’s cancer profile shows why the health system needs to think beyond curative treatment.
Among Nigerian women, breast cancer accounted for an estimated 32,278 new cases in 2022, followed by cervical cancer with 13,676 cases. Among men, prostate cancer was dominant, with 18,019 estimated cases.
Breast cancer alone accounted for 25.3 per cent of all estimated new cancer cases in both sexes, while prostate cancer represented 14.1 per cent and cervical cancer 10.7 per cent.
The mortality figures are equally important because they illustrate the consequences of late diagnosis, inadequate access to treatment and other barriers along the cancer care pathway.
Nigeria recorded an estimated 7,093 cervical cancer deaths in 2023, according to IARC’s cervical cancer elimination analysis. The same assessment estimated 13,676 new cervical cancer cases that year.
The figures are estimates generated through cancer modelling and should not be confused with a complete national registry of every cancer patient.
Nigeria is working to improve that evidence base. A 2026 presentation by researchers from the National Institute for Cancer Research and Treatment said fragmented and inconsistent cancer data had historically limited surveillance and policy evaluation, while NICRAT has been working towards a National Cancer Registry to centralise cancer information.
Better data matters because policymakers cannot properly determine where treatment centres, personnel, medicines and palliative services are most urgently required without knowing the size and distribution of the disease burden.
One of the most persistent misconceptions surrounding palliative care is that it begins when all other treatment has failed.
Nigeria’s national hospice and palliative care policy takes a broader approach. The policy states that palliative care should be available as a continuum from diagnosis and should address patients’ physical, psychosocial and spiritual needs. It also calls for integration across different levels of healthcare, including primary healthcare.
That is consistent with WHO guidance, which says palliative care can reduce suffering, improve quality of life and reduce unnecessary hospitalisation and healthcare use when introduced early.
For cancer patients, this can mean pain control, management of nausea and breathlessness, psychological support, nutritional support, social assistance and help for families dealing with the consequences of serious illness.
Pain management is particularly important. WHO identifies morphine as an essential medicine for moderate to severe pain and says access remains inadequate in many countries.
The challenge is therefore not simply whether Nigeria has a palliative care policy. It is whether patients can actually access the medicines, trained professionals and services that the policy envisages.
Nigeria’s own policy acknowledges that palliative and end of life care remains inaccessible to many Nigerians and calls for affordable services regardless of social status or place of residence.
The Health System Has Been Expanding, But Gaps Remain
There have been efforts to strengthen cancer treatment capacity.
The Federal Ministry of Health and Social Welfare says six oncology centres of excellence, including facilities in Ibadan, Enugu, Zaria, Sokoto, Benin and Abuja, are being upgraded with equipment including brachytherapy machines. It also reports the implementation of a Cancer Health Fund in six federal teaching hospitals to support indigent patients with breast, cervical and prostate cancers.
Government has also reported additional investments in cancer centres, specialised equipment and human capital development.
Yet capacity remains uneven, particularly when patients require specialised services outside major urban centres.
A 2025 Nigeria imPACT review supported by the International Atomic Energy Agency, WHO and other partners identified continuing gaps in the country’s cancer control system, while recommending stronger and more equitable cancer services.
This makes referral systems crucial. A hospital’s inability to provide a particular treatment should not automatically become a patient’s inability to receive care.
The Federal Government’s message therefore goes beyond the question of whether hospitals should admit terminally ill patients.
It raises a broader question about continuity of care in Nigeria’s health system.
A patient may begin with screening, receive a diagnosis, undergo surgery or chemotherapy, require radiotherapy, develop complications and eventually need palliative support. At each stage, the responsibility of the health system changes, but it does not necessarily end.
WHO’s cancer guidance similarly places palliative care within the broader continuum of cancer prevention, diagnosis, treatment and survivorship.
For families, this distinction can be decisive. Cancer can affect employment, household income, caregiving responsibilities and children’s welfare. A patient who cannot continue curative treatment may still need professional medical attention, pain relief and psychosocial support.
The evidence also shows that Nigeria’s challenge is becoming larger, not smaller. Cancer cases are rising globally, and IARC’s 2026 estimates project that new cancer cases worldwide could nearly double by 2050 without stronger prevention and control measures.
Nigeria therefore faces two linked tasks: detecting and treating more cancers earlier, while ensuring that patients whose disease cannot be cured are not abandoned by the healthcare system.
A cancer diagnosis may eventually become incurable. Care, however, should not become unavailable.